- Lipase-mediated stereoselective hydrolysis of aziridine-2-carboxylates
(KP 10-2001-0020162 issued)
- New sphingolipid derivatives and the composition for anti-cancer containing the same
(KP 10-2004-0051250 pending)
- Process for preparing iso-serine and its derivatives from aziridine-2-carboxylates
(KP 0425018 issued)
- p43 protein having the activity of immunological enhancement, angiogenesis suppression and tumor suppression
(KP 0425018 issued)
- Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component
(KP 0405919 issued)
- Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
(KP 0405918 issued)
- Processes for the preparation of an optically active 5,6-dioxopiperazine-2-carboxylic acid derivative
(KP 10-2003-0060437 pending)
- A process for preparing an optically pure 2-amino-1,3-diol or 2-amino-3-ol derivative
(KP 10-2003-0050338 pending)
- Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
(CHINA 3800008.3 pending)
- A oxazolidinone derivative, a process for the preparation thereof, and a composition the same
(KP 10-2003-2202371 pending)
- Optically active aziridine-2-carboxylate derivatives and a process for preparing them
(JP 2002-518164 pending)
- Optically active aziridine-2-carboxylate derivatives and a process for preparing them
(US 10/344,225 pending)
- Optically active aziridine-2-carboxylate derivatives and a process for preparing them
(EP 01957024.1 pending)
- Optically active aziridine-2-carboxylate derivatives and a process for preparing them
(KP 10-2003-7001902 pending)
- Process for preparing alpha-amino acids and their derivatives including phenylalanine and homophenylalanine and their intermediates
(KP 10-2003-7001903 pending)
- Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols
(KP 10-2003-7001904 pending)
- Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
(PCT PCT/KR03/00085 pending)
- Aminoacyl adenyate mimics having antimicrobial and antiparasitic activity and the pharmacetical composition comprising the same
(KP 10-2003-9965 pending)
- Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols
(PCT WO0212185A1 pending)
- Process for preparing alpha-amino acids and their derivatives including phenylalanine and homophenylalanine and their intermediates
(PCT WO0212184A1 pending)
- The process for preparing itraconazole intermediate
(KP 10-2002-0066328 pending)
- Optically active aziridine-2-carboxylate derivatives and a process for preparing them
(PCT WO0212186A1 pending)
- RNA Specifically Binding to NFATc
(KP 10-2002-0019425 pending)
- An intermediate of an optically active diarylalanine, its derivatives and process for preparing the same
(KP 10-2002-0004144 pending)
- A cell-based assay kit and method for measuring the activity of HCV NS5B replicase and NS3 helicase
(KP 10-2001-0067785 pending)
- Death Efeector Domain of Mammalian Apotpopsis Mediator, FADD, Inducing Bacterial Cell Death
(EP 00942486.2 pending)
- p43 Anti-Tumor Therapeutic Agent and Three dimensional Structure of Its Cytokine Domain
(US 10/049065 pending)
- Immlunological enhancement agent comprising N-terminal peptide of p43 as an effective component
(JP 2001-247841 pending)
- Immlunological enhancement agent comprising N-terminal peptide of p43 as an effective component
(US 09/930,169 pending)
- A kit for detecting apoptosis related gene
(KP 99-27964 pending)
- Anti-apoptotic Use of Human Glutaminyl-tRNA Synthetase with Consecutive Pro-apoptotic Mediators
(US 09/442,630 pending)
- A probe for diagnosing Candida Albicans and diagnostic method thereof
(KP 0279311 issued)
- Death Efeector Domain of Mammalian Apotpopsis Mediator, FADD, Inducing Bacterial Cell Death
(PCT PCT/kr00/00721 pending)
- p43 Anti-Tumor Therapeutic Agent and Three dimensional Structure of Its Cytokine Domain
(PCT PCT/KR00/00721 pending)
- Novel screening kit for selecting antibiotics
(KP 0252695 issued)
- A method for using cell growth inhibitor by suppressing the activity of aminoacyl-tRNA Synthetase
(KP 10-1998-0022837 pending)
|
|
|
